Demand Ischemia and Troponin Elevation
Pathophysiology and Diagnosis
- Demand ischemia (Type 2 MI) occurs when increased oxygen demand or decreased supply leads to myocardial injury without primary coronary thrombosis, as noted by the American College of Cardiology 1
- Any troponin elevation above the 99th percentile of a normal reference population indicates myocardial cell injury, which in the context of clinical ischemia qualifies as myocardial infarction, according to the European Heart Journal 1, 3
- The magnitude of troponin elevation correlates with mortality risk, with higher levels associated with worse outcomes, as reported in Circulation 4
- Troponin elevation in demand ischemia represents only about 5% of all troponin elevations detected clinically, as stated in Circulation 6
Management and Treatment
- The American College of Cardiology recommends identifying and treating the underlying cause of increased demand or decreased supply, and optimizing oxygen supply and demand 1, 5
- The European Heart Journal suggests ensuring adequate oxygenation and ventilation, correcting anemia if present, and considering supplemental oxygen if hypoxemic 2, 4, 5
- Controlling heart rate, managing hypertension, and providing adequate pain control are also crucial in reducing oxygen demand, as noted in the European Heart Journal and Circulation 2, 4, 5
Risk Stratification and Follow-up
- The European Heart Journal and Circulation report that troponin elevation serves as an independent predictor of substantial patient risk, and the risk of adverse outcomes increases proportionately with the absolute level of troponin elevation 4, 5
- Echocardiography to assess for wall motion abnormalities and structural heart disease, and non-invasive stress testing after resolution of acute illness to evaluate for underlying coronary artery disease, are recommended by the European Heart Journal and Circulation 2, 4, 5